Although, both NY-ESO-1 and p53 exhibit spontaneous humoral and CD4+ T cell immune responses in cancer patients who have antigen-expressing tumors, CD8+ T cell responses are undetectable against p53 in contrast to a strong induction of CD8+ T cell responses against NY-ESO-1 [3]. Here, CD4 is linked to cancer.